Ergot Alkaloids: Hepatic Distribution and Estimation of Absorption by Measurement of Total Radioactivity in Bile and Urine

Overview

Journal J Pharmacokinet Biopharm

Specialty Pharmacology

Date 1976 Feb 1

PMID 1271240

Citations 11

Authors

F Nimmerfall

J Rosenthaler

Affiliations

Soon will be listed here.

Citing Articles

Risks for animal health related to the presence of ergot alkaloids in feed.

Schrenk D, Bignami M, Bodin L, Chipman J, Del Mazo J, Grasl-Kraupp B EFSA J. 2024; 22(1):e8496.

PMID: 38264299 PMC: 10804272. DOI: 10.2903/j.efsa.2024.8496.

Ergovaline movement across Caco-2 cells.

Shappell N, Smith D In Vitro Cell Dev Biol Anim. 2006; 41(8-9):245-51.

PMID: 16409109 DOI: 10.1290/0504026R.1.

Ergovaline toxicity on Caco-2 cells as assessed by MTT, alamarBlue, and DNA assays.

Shappell N In Vitro Cell Dev Biol Anim. 2003; 39(7):329-35.

PMID: 12954076 DOI: 10.1290/1543-706X(2003)039<0329:ETOCCA>2.0.CO;2.

Ergotamine absorption and toxicity.

Orton D, Richardson R Postgrad Med J. 1982; 58(675):6-11.

PMID: 7088766 PMC: 2426226. DOI: 10.1136/pgmj.58.675.6.

Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.

Maurer G, Schreier E, Delaborde S, Nufer R, Shukla A Eur J Drug Metab Pharmacokinet. 1983; 8(1):51-62.

PMID: 6861794 DOI: 10.1007/BF03189581.

References

SLAYTOR M, Wright S . THE METABOLITES OF ERGOMETRINE AND LYSERGIC ACID DIETHYLAMIDE IN RAT BILE. J Med Pharm Chem. 1962; 5:483-91. DOI: 10.1021/jm01238a008. View

Harris P, RIEGELMAN S . Influence of the route of administration on the area under the plasma concentration-time curve. J Pharm Sci. 1969; 58(1):71-5. DOI: 10.1002/jps.2600580114. View

Gibaldi M, Feldman S . Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve. J Pharm Sci. 1969; 58(12):1477-80. DOI: 10.1002/jps.2600581211. View

Gibaldi M, Feldman S . Route of administration and drug metabolism. Eur J Pharmacol. 1972; 19(3):323-9. DOI: 10.1016/0014-2999(72)90098-2. View

Rowland M . Influence of route of administration on drug availability. J Pharm Sci. 1972; 61(1):70-4. DOI: 10.1002/jps.2600610111. View

Gibaldi M, BOYES R, Feldman S . Influence of first-pass effect on availability of drugs on oral administration. J Pharm Sci. 1971; 60(9):1338-40. DOI: 10.1002/jps.2600600909. View

Smith R . The biliary excretion and enterohepatic circulation of drugs and other organic compounds. Fortschr Arzneimittelforsch. 1966; 9:299-360. DOI: 10.1007/978-3-0348-4021-7_5. View

Meszaros J, Nimmerfall F, Rosenthaler J, Weber H . Permanent bile duct cannulation in the monkey. A model for studying intestinal absorption. Eur J Pharmacol. 1975; 32(02):233-42. DOI: 10.1016/0014-2999(75)90288-5. View

RIEGELMAN S, Rowland M . Effect of route of administration on drug disposition. J Pharmacokinet Biopharm. 1973; 1(5):419-34. DOI: 10.1007/BF01059666. View

10.

DENGLER H . [Methodical problems in clinical-pharmacological research]. Arzneimittelforschung. 1971; 21(10):1484-7. View

11.

Weis H, Dietschy J . Failure of bile acids to control hepatic cholesterogenesis: evidence for endogenous cholesterol feedback. J Clin Invest. 1969; 48(12):2398-408. PMC: 297497. DOI: 10.1172/JCI106206. View

12.

Bergstrom S, Danielsson H . On the regulation of bile acid formation in the rat liver. Acta Physiol Scand. 1958; 43(1):1-7. DOI: 10.1111/j.1748-1716.1958.tb01572.x. View